Mirimus

Mirimus

Verified
Producer of custom genetically-engineered mouse models with reverse gene silencing capabilities.

Launch date
Employees
Market cap
-
Net debt
-
Enterprise valuation
$8—12m (Dealroom.co estimates Mar 2011.)
New York City New York (HQ)
  • Edit
Get premium to view all results
DateInvestorsAmountRound
-investor

$0.0

round
investor

$0.0

round
N/A

$0.0

round
investor

$0.0

round
investor

$0.0

round
investor

$0.0

round
N/A

$400k

Grant
Total Funding000k

Recent News about Mirimus

Edit

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.